Join us for an in-depth exploration of the challenges and innovations in developing FDA-approved cannabinoid medications. From the groundbreaking discovery of THC in 1964 to today's cutting-edge research, we'll unpack the complex journey of turning promising cannabinoid research into approved therapeutics.

This episode delves into the intricate science of cannabinoid receptors, drug delivery innovations, and the role of artificial intelligence in drug development. Learn about synthetic cannabinoid analogs, novel delivery systems like nanoparticles, and how computational modeling is revolutionizing the field.

We'll also explore the potential therapeutic applications, from treating chemotherapy-induced nausea to emerging research in epilepsy and cancer treatment. Discover how researchers are working to overcome regulatory hurdles while maintaining rigorous scientific standards in this rapidly evolving field.